Astrazeneca Secures FDA Approval for New Breast Cancer Treatment
AstraZeneca secured FDA approval for its breast cancer drug Etcamah and reported positive Phase 3 trial data for lung cancer and COPD.
AstraZeneca got official approval from the FDA to sell a new breast cancer medicine, which means doctors can now prescribe it to patients. When a big drug company gets approval for a new medicine, it's usually a sign the company might make more money, so it's worth watching how investors react.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.